[Necrotizing community-acquired pneumonia secondary to influenza a (H1N1) super-infected by an invasive group A streptococcus].
Casalegno
J-S
JS
HCL, Laboratoire de Virologie, Centre de Biologie et Pathologie Est, 59 Boulevard Pinel, 69677 Bron, France. jean-sebastien.casalegno@chu-lyon.fr
Escuret
V
V
Celard
M
M
Bouscambert
M
M
Frobert
E
E
Mekki
Y
Y
Lina
G
G
Lina
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001469:Barotrauma / Q000209:etiology; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D004630:Emergencies; D017809:Fatal Outcome; D006491:Hemothorax / Q000209:etiology / Q000601:surgery; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000150:complications*; D008297:Male; D009336:Necrosis; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D011030:Pneumothorax / Q000209:etiology / Q000601:surgery; D012121:Respiration, Artificial / Q000009:adverse effects; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000628:therapy; D013290:Streptococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology; D013297:Streptococcus pyogenes / Q000472:pathogenicity*; D015163:Superinfection / Q000382:microbiology*; D013921:Thrombocytopenia / Q000209:etiology
D000900:Anti-Bacterial Agents